HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Accumulated Expenses came in at $11.0 million in Q4 2025, down 30.79% year-on-year from $15.9 million in Q4 2024, and down 30.79% on a QoQ basis from $15.9 million in Q4 2024.
HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Accumulated Expenses data on file, last reported at $11.0 million in Q4 2025.
- On a quarterly basis, Accumulated Expenses fell 30.79% year-over-year to $11.0 million in Q4 2025; TTM through Dec 2025 was $11.0 million, a 30.79% decrease from a year earlier, with the FY2025 full-year figure at $11.0 million, down 30.79% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $11.0 million, down from $15.9 million in the prior quarter.
- Over the last five years, Accumulated Expenses for HCM reached as high as $45.0 million in Q4 2023 and fell as low as $11.0 million in Q4 2025.
- Historically, Accumulated Expenses has averaged $25.1 million across 5 years, with a median of $15.9 million in 2024.
- Across the five-year window, Accumulated Expenses soared 274.17% in 2022 and sank 64.8% in 2024, its largest moves.
- Year by year, Accumulated Expenses stood at $11.3 million in 2021, then surged by 274.17% to $42.4 million in 2022, then gained by 6.14% to $45.0 million in 2023, then slumped by 64.8% to $15.9 million in 2024, then plunged by 30.79% to $11.0 million in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $11.0 million in Q4 2025, $15.9 million in Q4 2024, and $45.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.98 Mn |
| Dec 31, 2024 | 15.86 Mn |
| Dec 31, 2023 | 45.05 Mn |
| Dec 31, 2022 | 42.44 Mn |
| Dec 31, 2021 | 11.34 Mn |
| Dec 31, 2020 | 5.75 Mn |
| Dec 31, 2019 | 3.34 Mn |
| Dec 31, 2018 | 4.68 Mn |
| Dec 31, 2017 | 9.30 Mn |
| Dec 31, 2016 | 7.06 Mn |
| Dec 31, 2015 | 5.52 Mn |